Outcome of Board Meeting
Dear Sir, Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on 18 August 2017 had approved the Un-audited Financial Results of the Company for the quarter ended 30 June 2017. Further the Board took note of increase in manufacturing capacity of the Ibuprofen from 6200 TPA to 7200 TPA by conversion of existing multipurpose plant.... Notice Of The Board Meeting
This is to inform you that the meeting of the Board of Directors is scheduled to be held on Friday, the 18th day of August, 2017 inter-alia to consider and approve the un-audited financial results of the Company for the quarter ended 30 June 2017. Further, in terms of provisions of the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the "Trading Window" of the Company shall remain closed from 11 August 2017... Shareholding for the Period Ended June 30, 2017
IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here Statement Of Investor Complaints For The Quarter Ended 30 June 2017
Pending at the beginning of the quarter-NIL Received during the quarter-NIL Disposed of during the quarter-NIL Remaining unresolved at the end of the quarter-NIL Updates
Subject: Financial Results published in the newspaper Dear Sir, This is with reference to the extract of audited financial results for the quarter / year ended 31 March 2017 published in the newspapers i.e. Financial Express dated 28 May 2017, Business Standard dated 29 May 2017, Economic Times dated 29 May 2017 and Punjabi Jagran dated 28 May 2017.... Financial Results For Mar 31, 2017
Dear Sir, Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you the Board of Directors in its meeting held on 27 May 2017 had approved the Following: 1.Audited Financial Results for the Quarter/ Financial year ended 31 March 2017 2.Acceptance of Resignation of Mr Vijay Singla from directorship of the company with effect from 27 May 2017.... Outcome of Board Meeting
Dear Sir, Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you the Board of Directors in its meeting held on 27 May 2017 had approved the Following: 1.Audited Financial Results for the Quarter/ Financial year ended 31 March 2017 2.Acceptance of Resignation of Mr Vijay Singla from directorship of the company with effect from 27 May 2017.... Closure of Trading Window
This is to inform you that the meeting of the Board of Directors is scheduled to be held on Saturday, the 27th day of May, 2017 inter-alia to consider and approve the audited financial results of the Company for the quarter and year ended 31 March 2017. Further, in terms of provisions of the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the "Trading Window" of the Company shall remain closed from 21 May 2017 and... Closure of Trading Window
This is to inform you that the meeting of the Board of Directors is scheduled to be held on Saturday, the 27th day of May, 2017 inter-alia to consider and approve the audited financial results of the Company for the quarter and year ended 31 March 2017. Further, in terms of provisions of the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the "Trading Window" of the Company shall remain closed from 21 May 2017 and...